Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma

被引:0
|
作者
Tadashi Matsunaga
Fumiaki Sasaki
Mutsuro Ohira
Kohei Hashizume
Akira Hayashi
Yutaka Hayashi
Hideo Mugishima
Naomi Ohnuma
机构
[1] Department of Pediatric Surgery,
[2] Graduate School of Medicine,undefined
[3] Chiba University,undefined
[4] Chiba,undefined
[5] Japan,undefined
[6] ,undefined
[7] Japanese Study Group for Pediatric Liver Tumor (JPLT),undefined
[8] Japan,undefined
[9] Department of Pediatric Surgery,undefined
[10] Graduate School of Medicine,undefined
[11] Chiba University,undefined
[12] 1-8-1 Inohana,undefined
[13] Chuo-ku,undefined
[14] 260-8677,undefined
[15] Chiba,undefined
[16] Japan,undefined
来源
关键词
Hepatoblastoma Lung metastasis Recurrence Stem cell transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:142 / 146
页数:4
相关论文
共 50 条
  • [21] Transarterial chemoembolization in the treatment of hepatoblastoma in children
    Vogl, Thomas J.
    Scheller, Albert
    Jakob, Ursula
    Zangos, Stefan
    Ahmed, Medhat
    Nabil, Mohamed
    EUROPEAN RADIOLOGY, 2006, 16 (06) : 1393 - 1396
  • [22] Treatment optimization for recurrent hepatoblastoma: retrospective study from a hepatoblastoma cohort in Southern China
    Yuanqi Wang
    Huadong Chen
    Yixuan Liu
    Han Xiao
    Xiaoshuai Wang
    Zhihai Zhong
    Pengfei Gao
    Zhichong Zhang
    Jinbiao She
    Juncheng Liu
    Leilei Huang
    Hong Jiang
    Pediatric Surgery International, 2022, 38 : 1031 - 1039
  • [23] Treatment optimization for recurrent hepatoblastoma: retrospective study from a hepatoblastoma cohort in Southern China
    Wang, Yuanqi
    Chen, Huadong
    Liu, Yixuan
    Xiao, Han
    Wang, Xiaoshuai
    Zhong, Zhihai
    Gao, Pengfei
    Zhang, Zhichong
    She, Jinbiao
    Liu, Juncheng
    Huang, Leilei
    Jiang, Hong
    PEDIATRIC SURGERY INTERNATIONAL, 2022, 38 (07) : 1031 - 1039
  • [24] Characteristics and Outcome of Children with Hepatoblastoma and Lymph Node Involvement
    Liu, A. P. -Y.
    Yuan, X.
    Chung, P. H. -Y.
    Chiang, A.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S270 - S271
  • [25] Outcome of Children with Hepatoblastoma: Analysis of a Single Center Experience Over the Last 23 Years
    Kechiche, N.
    Farhani, R.
    Chabchoub, I.
    Lamiri, R.
    Sboui, H.
    Ammar, N.
    Lassaad, S.
    Ben Ahmed, S.
    Mongi, M.
    Belguith, M.
    Nouri, A.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S312 - S313
  • [26] Outcome of Locally Recurrent and Metastatic Angiosarcoma
    G. Lahat
    A. R. Dhuka
    S. Lahat
    K. D. Smith
    R. E. Pollock
    K. K. Hunt
    V. Ravi
    A. J. Lazar
    D. Lev
    Annals of Surgical Oncology, 2009, 16 : 2502 - 2509
  • [27] Outcome of Locally Recurrent and Metastatic Angiosarcoma
    Lahat, G.
    Dhuka, A. R.
    Lahat, S.
    Smith, K. D.
    Pollock, R. E.
    Hunt, K. K.
    Ravi, V.
    Lazar, A. J.
    Lev, D.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (09) : 2502 - 2509
  • [28] Refractory and Recurrent Hepatoblastoma: Epidemiology, Current Treatments and Outcome: The French Experience
    Vermeulen, S.
    Aerts, I.
    Taque, S.
    Mallon, B.
    Brugieres, L.
    Fresneau, B.
    Thebaud, E.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S316 - S316
  • [29] Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: Stable radiographic disease with decreased AFP
    Marsh, Anne M.
    Lo, Louise
    Cohen, Ronald A.
    Feusner, James H.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (05) : 939 - 940
  • [30] Treatment Outcome of Hepatoblastoma - Single Center Experience in Korea
    Hahn, S. M.
    Ihn, K.
    Ahn, W. K.
    Lyu, C. J.
    Han, J. W.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S287 - S287